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Abstract
Background: Transient ischemic attack (TIA) patients are at high risk of recurrent vascular events; timely
management can reduce that risk by 70%. The Protocol-guided Rapid Evaluation of Veterans Experiencing New
Transient Neurological Symptoms (PREVENT) developed, implemented, and evaluated a TIA quality improvement
(QI) intervention aligned with Learning Healthcare System principles.
Methods: This stepped-wedge trial developed, implemented and evaluated a provider-facing, multi-component
intervention to improve TIA care at six facilities. The unit of analysis was the medical center. The intervention was
developed based on benchmarking data, staff interviews, literature, and electronic quality measures and included:
performance data, clinical protocols, professional education, electronic health record tools, and QI support. The
effectiveness outcome was the without-fail rate: the proportion of patients who receive all processes of care for
which they are eligible among seven processes. The implementation outcomes were the number of
implementation activities completed and final team organization level. The intervention effects on the without-fail
rate were analyzed using generalized mixed-effects models with multilevel hierarchical random effects. Mixed
methods were used to assess implementation, user satisfaction, and sustainability.
Discussion: PREVENT advanced three aspects of a Learning Healthcare System. Learning from Data: teams
examined and interacted with their performance data to explore hypotheses, plan QI activities, and evaluate
change over time. Learning from Each Other: Teams participated in monthly virtual collaborative calls. Sharing Best
Practices: Teams shared tools and best practices. The approach used to design and implement PREVENT may be
generalizable to other clinical conditions where time-sensitive care spans clinical settings and medical disciplines.
Trial registration: clinicaltrials.gov: NCT02769338 [May 11, 2016].
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Background
With the proliferation of electronic health records and
increased emphasis on Learning Healthcare Systems,
healthcare teams are being tasked with responding to
data-driven quality problems [1]. Teams may deploy a
variety of quality improvement (QI) strategies and sys-
tems redesign approaches to improve performance,
depending on the complexity and scope of the problem.
This description of the rationale, implementation strat-
egy, and evaluation plan of the Protocol-guided Rapid
Evaluation of Veterans Experiencing New Transient
Neurological Symptoms (PREVENT) trial details an ap-
proach to developing and evaluating a multi-component
QI intervention for a complex, time-sensitive clinical
problem that involves several clinical disciplines and is
consistent with the principles of the Learning Healthcare
System model. This report adheres to the Revised Stan-
dards for Quality Improvement Reporting Excellence
(SQUIRE 2.0) [2, 3].
The problem being addressed
Approximately 8500 Veterans with transient ischemic
attack (TIA) or ischemic stroke are cared for in a
Department of Veterans Affairs (VA) Emergency De-
partment (ED) or inpatient ward annually in the United
States [4]. Patients with TIA generally present with
transient neurological symptoms of presumed ischemic
etiology [5]. TIA patients at high risk of recurrent vascular
events [6–8], however, interventions which deliver timely
TIA care can reduce that risk by up to 70% [9–12]. Des-
pite the known benefits of timely TIA care, data from both
selected private-sector United States hospitals (i.e., facil-
ities that have implemented stroke quality improvement
programs) [13] and from the VA healthcare system have
identified gaps in TIA care quality. For example, only 51%
of Veterans who were eligible received carotid imaging as
part of their TIA care [14]. Moreover, the majority of VA
facilities do not have a TIA-specific protocol [15].
Objective
The objective of the PREVENT trial was to develop, im-
plement, and evaluate a multi-component, QI interven-
tion to improve the quality of care for Veterans with
TIA that could be scaled to serve the full spectrum of
VA medical centers, ranging from small facilities with
few specialist resources to the most complex and well-
resourced facilities with access to comprehensive aca-
demic medical centers. The Consolidated Framework for
Implementation Research (CFIR) guided the development
of the PREVENT intervention, its accompanying imple-
mentation strategies, and its evaluation plan [16, 17]. Our
approach contributed to the development of a Learning
Healthcare System and may be generalizable to QI inter-
ventions that target healthcare teams [18].
Methods
Context
Within the VA, quality measurement and systems re-
design are integrated into the healthcare system within
administration and clinical operations [19, 20]. Although
stroke care quality metrics are reported, there is cur-
rently no VA system-wide focus on TIA care quality.
TIA is a clinical condition that is relatively common and
for which there is a time-sensitive imperative to provide
diagnostic and management processes of care. However,
there is no existing VA quality measurement or “top-
down” mandate for QI related to TIA care. Nevertheless,
because of the demonstrable gaps in the quality of TIA
care for Veterans, VA leadership, namely in neurology
and emergency medicine, provided robust support for a
TIA quality improvement program.
Quality improvement intervention development
The development of the PREVENT intervention [21–24]
was based on a systematic assessment of TIA care per-
formance at VA facilities nationwide as well as critical
barriers and facilitators of TIA care performance using
four sources of information: baseline quality of care data
[14], staff interviews [15], existing literature [25–28], and
validated electronic quality measures [14].
Baseline quality of care data
The first national benchmarking study of TIA care quality
in the VA included patients cared for in any VA ED or an
inpatient setting during federal-fiscal year 2014 [29]. Among
N = 8201 patients in 129 facilities, performance varied
across elements of care from brain imaging within 2 days of
presentation (88.9%) to high/moderate potency statin within
7 days post-discharge (47.2%). Performance also varied sub-
stantially across facilities. Performance was higher for ad-
mitted patients than for patients cared for only in EDs, with
the greatest disparity for carotid artery imaging: 75.6% ver-
sus 25.3% (p < 0.0001). These data provided justification for
developing a QI project to improve TIA care quality.
Staff interviews
Interviews with staff members involved in the care of pa-
tients with TIA from multiple disciplines (neurology,
emergency medicine, nursing, pharmacy, primary care,
hospitalist medicine, radiology, vascular surgery, cardi-
ology, ophthalmology, systems redesign, and quality
management) at 14 diverse VA facilities identified bar-
riers to providing high quality TIA care including: gaps
in knowledge, lack of performance data, uncertainty
about how to engage in QI, inadequate care coordin-
ation, and information technology barriers [15, 29]. The
PREVENT intervention was designed to address these
barriers by drawing upon existing VA resources (e.g.,
staffing, VA data systems, etc) (Fig. 1).
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Prior literature
Several studies have demonstrated that providing timely
diagnosis and management improves care and outcomes
for patients with TIA [9–12, 27, 28]. For example, three
effectiveness studies included algorithms or protocols
that facilitated the timely delivery of care for patients
with TIA. Based on this research, PREVENT included al-
gorithms and protocols to promote timely delivery of
the guideline-concordant processes of care that have
been associated with improved outcomes [9].
Validated electronic quality measures
Electronic quality measures were developed using elec-
tronic health record data and were validated against
chart review [30]. A random sample of 763 TIA or
minor ischemic stroke patients cared for in 45 VA facil-
ities was used to construct electronic versions of 31
existing quality measures [30]. The measures with the
most robust performance against chart review became
the PREVENT measures [30].
Quality improvement intervention description
The PREVENT QI intervention targeted facility pro-
viders not individual patients. External facilitation was
provided by the study team, which included a nurse
(with quality management and clinical nursing experi-
ence), a general internist (with QI and stroke clinical
care experience), implementation scientists (from diverse
backgrounds including health psychology, education and
medical anthropology), and a senior data scientist. The
participating facility teams were diverse but generally
included members from neurology, emergency medicine,
nursing, pharmacy, and radiology; some teams also in-
cluded hospitalists, primary care staff, education staff,
telehealth staff, ophthalmologists, or systems redesign
staff. The primary site champion was the person desig-
nated as being responsible for stroke care quality at the
participating facility. Therefore, for the majority of sites,
the champion was a neurologist, but at one site the
champion was an ED nurse and at another site the role
of champion was shared by staff from neurology and phar-
macy. The PREVENT QI intervention included five
Fig. 1 Intervention Components Mapped onto Barriers to Providing Quality Care. Figure 1 displays the barriers to providing excellent quality of
care for patients with transient ischemic attack (TIA) or minor stroke that were identified through interviews with front-line clinicians as well as
the components of the PREVENT program that were designed to overcome each barrier
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components [1]: quality of care reporting system [2], clin-
ical programs [3], professional education [4], electronic
health record tools, and [5] QI support including a virtual
collaborative (Fig. 1).
Quality of care reporting system: audit and feedback
The web-based PREVENT Hub (Fig. 2) provided data
about a broad range of processes of care (e.g., brain im-
aging), healthcare utilization (e.g., proportion of patients
with a primary care visit within 30-days of the index
TIA), and other aspects of care (e.g., proportion of TIA
patients who left against medical advice). These data
were updated monthly for every VA facility. Aggregated
data were presented at the facility level (not the patient
or provider level) and placed in context by being dis-
played alongside suggested targets and VA national
rates. The PREVENT Hub allowed users to customize
views to examine quality over time and to compare
themselves with other facilities. Users could explore
hypotheses about whether their performance varied for
patients who presented on weekdays versus weekends,
for patients who were admitted to the hospital versus
discharged from the ED, or for patients with neurology
consultation versus without neurology consultation.
Fig. 2 The PREVENT Web-Based Hub. The home page of the web-based PREVENT Hub included a prominent display of the facility without-fail
rate (upper left red box) and the pass rates for each of the seven key processes of care (in blue text)
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Clinical protocols
Several clinical programs were developed and shared on the
PREVENT Hub. For example, a pharmacist-based TIA
medication management protocol was developed to im-
prove medication-related processes of TIA care (e.g., hyper-
tension and hyperlipidemia management). The pharmacy
protocol utilized existing VA pharmacy staff in the inpatient
or ED settings with hand-offs to pharmacists embedded in
the primary care teams. In addition, a templated note and
checklist were created for VA primary care nurses. PRE-
VENT site teams developed ED-based protocols for TIA
patients which were also shared on the PREVENT Hub.
Professional education
The PREVENT staff education materials were diverse,
including: slide sets (with speaker notes) designed specif-
ically for physicians and residents, pharmacists, and
nurses; guidelines and article reprints; videos (one
described the importance of providing timely TIA care
and one demonstrated a clinical team reflecting on qual-
ity of care data, evaluating progress toward goals, and
planning QI activities in response to data); as well as
pocket-cards and posters. Locally-generated educational
materials were also shared on the Hub.
Electronic health record tools
A variety of electronic health record tools were available
for PREVENT sites to adapt including: order menus,
note templates, and a patient identification tool. The
note templates were developed using reminder dialogues
to enable teams to monitor when templates were used.
The patient identification tool was developed to identify
individual TIA patients who were seen in a facility in the
ED or inpatient ward so that the site teams could ensure
that highest quality care was being delivered in real time
(as opposed to waiting for retrospective data).
Quality improvement support & virtual collaborative
Active implementation of PREVENT involved a full-day
kickoff meeting. The kickoff included all relevant staff
members at a participating site and study team mem-
bers, some participated in person and others participated
via videoconference. The kickoff was designed to be fun,
engaging, educational, and productive. The PREVENT
study team members explicitly developed the agenda
with the belief that the most important resource for the
kickoff was the time and attention of the participating staff
members, with the event providing a crucial opportunity
for team formation (at many sites team members were
meeting each other for the first time at the kickoff).
The kickoff began with presentations, videos, and ac-
tivities to create a sense of excitement and empower-
ment about improving care and outcomes for patients
with TIA. The facility team used the PREVENT Hub to
explore their facility-specific quality of care data and
identify processes of care with the largest gaps in quality
for the greatest number of patients. Using approaches
from systems redesign, facility team members brain-
stormed about barriers to providing highest quality of
care, identified solutions to address barriers, ranked
solutions on an impact-effort matrix, and developed a
site-specific action plan that included high-impact/low-
effort activities in the short-term plan and high-impact/
high-effort activities in the long-term plan. Throughout
the kickoff, the facility team was introduced to PRE-
VENT components (e.g., videos from the education pro-
gram and the pharmacy clinical protocol) as well as
strategies for engaging in key QI activities such as
reflecting and evaluating, goal setting, and planning.
Local QI plans were entered into the PREVENT Hub, and
metrics were tracked allowing teams to monitor perform-
ance over time. PREVENT site teams could learn from the
overall community by identifying which QI activities either
did or did not achieve improvement in metrics at other sites.
During the one-year active implementation period, the
teams joined monthly PREVENT collaborative confer-
ences which served as a forum for facility team members
to share progress on action plans, articulate goals for the
next month, and review any new evidence or tools [31].
The monthly collaborative conferences were conducted via
a shared meeting platform that allowed for screen sharing
and instant messaging; videoconferencing was also occa-
sionally used. During each collaborative conference, invited
speakers with expertise related to cerebrovascular risk fac-
tor management, VA healthcare administration, or systems
redesign reviewed topics of interest using cases to stimulate
discussion, identify barriers, and brainstorm about solu-
tions. Participants received continuing education credits. At
the end of the one-year active implementation period, the
collaborative call was conducted via video-conference and
was used to acknowledge the implementation accomplish-
ments of the site which was being promoted from active
implementation to sustainability. Facility leadership was in-
vited to celebrate the successes of the local team.
Evaluation approach
A five-year stepped-wedge [32, 33] Hybrid Type II [34]
implementation trial included six participating sites
where active implementation was initiated in three
waves, with two facilities per wave (Fig. 3). The unit of
analysis was the VA facility. Stepped-wedge designs are
increasingly being used in health services and implemen-
tation research when the intervention is not imple-
mented at the individual patient level but is rather
implemented sequentially within participating clusters
[21, 22, 35, 36]. In stepped-wedge designs, all of the
clusters (i.e., individual participating VA facilities) begin
with a control (baseline) condition and then initiate the
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intervention as the study progresses. The PREVENT trial
involved three phases: a 1 yr-baseline period, a one-year
active implementation period (that began 13months
after the start of the baseline period, providing 1 month
for facility teams to initiate QI activities), and a 1-year
sustainability period (following the end of active imple-
mentation; Fig. 3). The evaluation involved four assess-
ments of PREVENT: effectiveness, users’ assessment,
implementation, and sustainability. PREVENT was regis-
tered with clinicaltrials.gov (NCT02769338) and received
human subjects (institutional review board [IRB]) and
VA research and development committee approvals.
Primary effectiveness outcome
The primary effectiveness outcome was the “without-fail”
rate, defined as the proportion of Veterans with TIA who
received all of the processes of care for which they were
eligible from among seven processes of care: brain im-
aging, carotid artery imaging, neurology consultation,
hypertension control, anticoagulation for atrial fibrillation,
antithrombotics, and high/moderate potency statins [37].
These seven measures were included in the without-fail
rate because they are both guideline-recommended pro-
cesses of care and they have been associated with im-
provements in TIA patient outcomes [37]. The without-
fail rate is sometimes also referred to as “defect-free” care
[38, 39]. It is an all-or-none measure of quality, which as-
sesses for an individual patient whether they either did
(“passes” the without-fail measure), or did not (“fails” the
without-fail measure) receive all of the elements of care
for which they were eligible. The without-fail rate was cal-
culated at the facility level based on electronic health rec-
ord data using validated algorithms [14].
The secondary effectiveness outcomes included: the
seven individual processes of care that were included in
the without-fail measure, the consolidated measure of
quality which describes the proportion of care patients re-
ceived among the processes for which they were eligible
(e.g., for a patient who received two processes of care but
who was eligible for four processes of care, their consoli-
dated quality measure would be 50%, whereas their
without-fail rate would be 0%), and patient outcomes (i.e.,
90-day recurrent stroke and 90-day all-cause mortality).
Quantitative analysis plan: effectiveness assessment
Generalized mixed-effects models at the patient level with
random effects for sites were used to analyze the PRE-
VENT intervention effects on the without-fail rate during
the active implementation period compared with the base-
line period [40]. For the primary effectiveness analysis, the
main comparison was the mean facility without-fail rate
across the six sites during the baseline data period versus
the active implementation data period; adjusting for wave
and site variations. The primary analysis included the first
TIA event per patient. In sensitivity analyses, we included
all TIA events and we will also excluded patients ≥90-
years old (because care for such patients may appropri-
ately not include all of the processes of care which were
included in the without-fail rate).
Several secondary effectiveness analyses were pre-
specified, including [1]: an examination of how the
without-fail rate changed in the PREVENT sites compared
with VA facilities matched on the basis of TIA patient vol-
ume, facility complexity (i.e., teaching status, intensive
care unit level),and baseline without-fail rate (with six
controls for each intervention site); this analysis allowed
for consideration of temporal changes in care [2]; an
examination of individual processes of care across the six
sites from the baseline period to active implementation
period (e.g., how did receipt of high or moderate potency
statins change from baseline to active implementation)
[3]; an assessment of change in the consolidated measure
of quality from baseline to active implementation; and [4]
a comparison of the 90-day recurrent stroke rate and the
90-day all-cause mortality rate, before versus after active
implementation. For each of these secondary analyses,
the multivariable models included adjustment for wave
site variations, and baseline comorbidities. Specifically,
Fig. 3 PREVENT Stepped-wedge Design. The stepped-wedge design included two sites per wave and a total of three waves. The study included:
a 12-month baseline period (yellow); a12-month post-implementation period (orange), which began with a kick-off (brown), and during which
the site teams participated in monthly virtual collaborative sessions (telephone symbol); and a sustainability period (blue)
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individual risk-adjustment models were created for each
process of care and for each patient outcome. The individ-
ual processes of care, the consolidated measure of quality,
the 90-day recurrent stroke rate, and the 90-day mortality
rate were considered secondary outcomes because the
stepped-wedge study was designed to have adequate
power (see Sample Size section below) to identify
differences in the primary effectiveness outcome (the
without-fail rate) and not the secondary outcomes.
Mixed methods evaluation plan: user satisfaction,
implementation and sustainability assessments
Table 1 summarizes the qualitative data collection meth-
odology including: semi-structured interviews, observa-
tions, and Fast Analysis and Synthesis Template (FAST)
facilitation tracking [41]. Interviews were conducted in-
person during site visits or by telephone at baseline, 6-
months and 1-year after active implementation, and at the
end of sustainability. Key stakeholders included staff in-
volved in the delivery of TIA care, their managers, and fa-
cility leadership; we also accepted “snowball” referrals
from key stakeholders. Upon receipt of verbal consent, in-
terviews were audio-recorded. The audio-recordings were
transcribed verbatim. Transcripts were de-identified and
imported into Nvivo12 for data coding and analysis. Using
a common codebook, two team members independently
coded identical transcripts for the presence or absence of
CFIR constructs as well as magnitude and valence for four
selected CFIR implementation constructs (i.e., Goals &
Feedback, Planning, Reflecting & Evaluating, and Cham-
pions). The project team met to review and discuss simi-
larities and differences in the coding until a shared
understanding of each item in the codebook was devel-
oped. In addition to the interview data, the study team
conducted formal debriefings after each kickoff, site visit,
and collaborative call. These observations were recorded
and transcribed for analyses. We also used the FAST
template, which is a structured electronic log, as a rapid,
systematic method for extracting key concepts across data
sources including interviews, collaborative calls, and Hub
utilization data [41]. We adapted an external facilitator
tracking sheet to prospectively collect the dose and
contents of external facilitation provided by the study
team to participating facility teams [42]. We evaluated
local organizational culture using the Organizational Cul-
ture Assessment Instrument [43, 44]. Finally, we collected
audience-response system (ARS) feedback and written
evaluations about program components during kickoffs.
Table 1 Qualitative Data Collection Plan
FOCUS OF INQUIRY DATA PERIOD METHOD PARTICIPANTS
Structure: TIA protocol; TIA
providers
Process: how clinical teams use
data to improve quality; local
context
Formal, semi-structured,
qualitative interviews
Baseline
6 months into active
implementation
12 months into active
implementation
Sustainability
Audio-recorded &
transcribed interviews
Providers who care for and
support patients with TIA
Structure: Team composition
Process: Team formation;
impact evaluation; action
planning
Observations of team kickoffs
for active implementation
After baseline at the
start of active
implementation
Structure: Clinical providers’
attendance and participation
Process: Community of care
interactions; implementation
progress
Observations of Virtual
Collaborative Calls
Monthly 1 Hour Calls
Structure: Local front-line pro-
viders involved in TIA care
Process: Team dynamics;
implementation progress; use
of data
Observations of facility visits Post Visit Debriefings Audio-recorded &
transcribed interviews &
field notes
Structure: Role and service of
key informants
Process: Use of
implementation strategy;
implementation progress
FAST* template: a rapid,
systematic method for capturing
key concepts across data sources
Project Duration FAST Template
Structure: Facility team
members engaged in quality
improvement
Process: Facilitation contents
and dose
External Facilitation Tracking
Sheet
FAST Template and
Facilitator notes
Providers who locally adapt
PREVENT to improve quality of
TIA care
*FAST refers to the Fast Analysis and Synthesis Template [41]
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Users’ assessment of the program
The assessment of satisfaction with the PREVENT pro-
gram was evaluated using interview data, ARS, and survey
data. Satisfaction was defined as program acceptability,
the perception among front-line implementers that PRE-
VENT was palatable or satisfactory based on content,
complexity, or comfort. We derived the users’ assessment
of the intervention using the intervention characteristics
domain from CFIR. We sought to identify the components
of the intervention that were most useful or most import-
ant to the facility team members.
Implementation outcomes and evaluation
PREVENT employed three primary implementation
strategies [1]: team activation via audit and feedback,
reflecting and evaluating, planning, and goal setting [2];
external facilitation; and [3] building a community of
practice. In addition, PREVENT allowed for local adap-
tation of the intervention components and took advan-
tage of peer pressure while providing facilitation support
to the site champion. The two primary implementation
outcomes were the number of implementation activities
completed during the one-year active implementation
period and the final level of team organization (defined
as the Group Organization [GO Score]) [45, 46] for
improving TIA care at the end of the 12-month active
implementation period. The number of implementation
activities completed was scored for each site by the re-
search team using a rubric designed for PREVENT. The
GO Score [45, 46] was a measure of team activation on
a 1–10 scale for improving TIA care based on specified
provider practices. Scores between 1 and 3 denoted a
beginning level of organization with no facility wide
approach, 4–5 reflected a developing approach, 6–7
denoted basic proficiency, 8 indicated intermediate
proficiency, and 9–10 reflected a TIA system that was
implemented facility-wide and that could sustain key
personnel turnover.
Using a mixed-methods approach grounded in the
CFIR, we examined and evaluated the degree to which
the sites engaged in the three primary implementation
strategies; the association between implementation strat-
egies and implementation success; contextual factors as-
sociated with implementation success; the association
between implementation strategies and the without-fail
rate; and the association between implementation out-
comes and the without-fail rate. In addition, we de-
scribed the dose, type, and temporal trends in external
facilitation that was provided to each site during active
implementation.
Sustainability evaluation
The sustainability analysis included both a comparison
of the change in the without-fail rate from the baseline
data period to the sustainability period and from the ac-
tive implementation period to the sustainability period.
We constructed mixed-effects models accounting for
random effects for sites as described above for the effect-
iveness evaluation and explored whether sites with the
greatest use of their own quality data demonstrated the
greatest program sustainability.
Site selection
Sites were invited to participate on the basis of demon-
strated gaps in quality of care; specifically, if they had
baseline without-fail rates of < 50%. All VA acute care
facilities with at least ten eligible TIA patients per year
were rank ordered in terms of the without-fail rate. Invi-
tations were sent via email beginning with facilities with
the greatest opportunity for improvement. Recruitment
continued until six facilities agreed to participate. Al-
though some stepped-wedge trials randomly assign facil-
ities to waves (for example in a cluster randomized
controlled trial design), PREVENT sites were allocated
to waves pragmatically based on the ability to schedule
baseline and kickoff meetings.
Power & Sample Size
The methods used for the sample size design and power
calculation for this stepped-wedge trial have been reported
elsewhere [36]. Briefly, the six-site, stepped-wedge design
provided > 90% power to detect an improvement in the
mean facility without-fail rate from 25% during the base-
line period to > 45% during the active implementation
period. The goal for the sample size was to recruit sites
with ≥50 TIA patients per year; however, power was pre-
served with ≥30 TIA patients per year. Fig. 4 provide the
plots of the power for testing the intervention effect H0 :
θ = 0, H1 : θ = θ
M for the intervention effect size θM ran-
ging from 0.1 to 0.3; allowing for a potential decrement in
intervention effect over time. Specifically, we hypothesized
that the effectiveness of the intervention would be more
robust during the active implementation phase and less
robust during sustainability. The panels in Fig. 4 were
based on a total of 6 sites (where a site was a single VA fa-
cility) with a site size of 30, 50 and 70 (TIA patients cared
for at a single VA facility). The results demonstrated rea-
sonable power (greater than or equal to 0.90) for detecting
the intervention effect when the effect size is at least 0.20
with a site size no less than 30. The coefficient of variation
(CV) was set at 0.2, 0.4, 0.6, and 0.8 to cover a wide range
of the between-site variation. The CV seemed to have little
effect on power (Fig. 4).
Results
We have described the development, implementation, and
evaluation of a multi-component provider-facing QI inter-
vention to improve TIA care at six VA facilities [22–24].
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Results of the planned analyses will be submitted for peer-
review as those data become available.
Discussion
Key strengths of the approach to developing this QI
program involved grounding the program in data from
multiple sources including interview data to understand
the needs of front-line providers across a diverse set of
facilities and across disciplines [15]; validation evidence
identifying processes of care that could be obtained as
electronic quality measures which facilitates ongoing
performance measurement and scalability [14]; bench-
marking data identifying the gaps in care that should
serve as targets for quality improvement, especially pro-
cesses with large opportunities for improvement for
large numbers of potentially eligible patients [14]; and
evidence from the existing literature about processes of
care that are most robustly associated with improved pa-
tient outcomes [25–28]. The strengths of the evaluation
plan included both the grounding in the CFIR model
and the explicit evaluation of implementation strategies
across diverse local contexts.
The PREVENT program was positively aligned with
the model of the Learning Healthcare System. In the
Institute of Medicine’s book Best Care at Lower Cost,
the Learning Healthcare System was described as an
Fig. 4 PREVENT Sample Size Design. The panels display how the power curves vary with changes in the coefficient of variation (CV)
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approach where “clinical informatics, incentives, and cul-
ture are aligned to promote continuous improvement
and innovation, with best practices seamlessly embedded
in the delivery process and new knowledge captured as
an integral by-product of the delivery experience.” [47]
Already recognized as an example of a stand-out
organization that harnesses the power of data to improve
the health of the populations it serves [48, 49], the VA
was the first federal agency to endorse the Learning
Healthcare System’s core values. The design of PRE-
VENT advanced three aspects of a Learning Healthcare
System. If PREVENT successfully improves TIA care
quality, then we will work with our partners in VA cen-
tral office to disseminate the program to all VA facilities.
Learning from data
The PREVENT Hub, unlike static performance dash-
boards, allowed teams to examine and interact with their
performance data to explore hypotheses, plan QI activ-
ities, and evaluate change over time. Although audit and
feedback has been demonstrated to be effective in QI,
we have little insight into how teams use data to im-
prove quality [50]. The PREVENT study provided an
opportunity to learn how teams use data to inform QI
activities. The patient identification tool provided teams
with patient-level, actionable information to identify pa-
tients in real-time to ensure that every patient received
all the care they needed; this tool is generalizable to
other time-sensitive clinical conditions where patients
seek care in the ED or inpatient settings.
Learning from each other
Site teams participated in monthly collaborative calls to
learn about relevant topics, share strategies for overcom-
ing challenges to providing highest care quality, and
cultivate a sense of community. PREVENT teams were
multidisciplinary, providing opportunities to learn across
disciplines. For example, although the role of
pharmacist-delivered care is well recognized for many
clinical conditions, it has been underutilized for the care
of patients with stroke or TIA. Given that many TIA
process of care involve medication management, collab-
oration with pharmacy staff offers great promise for
delivering guideline-concordant care [51].
Sharing best practices
Facility-based teams shared tools and best practices in a
rich and growing library of diverse resources.
Several limitations of the PREVENT program merit
description. The primary limitation of PREVENT was
the implementation only within VA hospitals which have
the benefit of a unified electronic health record. If this
program is found to be effective, then future research
should evaluate its implementation in non-VA settings.
Second, because several implementation strategies were
deployed, it may be difficult to disentangle the unique
effects of each strategy. However, we designed multiple
data collection sources to capture the effects of each
implementation strategy on implementation success
using rigorous evaluation methodology. Third, making a
diagnosis of TIA can be clinically challenging and some
patients who receive a diagnosis code for TIA may well
have an alternative diagnosis. Although we know that
some of the patients who were coded as having a TIA
did not have actually had a TIA, we have neither
observed differential miss-classification either across fa-
cilities nor across time [30]. In other words, potential
TIA miscoding is likely to exist across all of the sites
and will likely exist during baseline, active implementa-
tion, and sustainability phases. Therefore, it is unlikely
that differential TIA miscoding will bias the examination
of the effect of the intervention. If, however, the TIA
miscoding rate was unexpectedly high, and patients were
not getting TIA processes of care because they did not
actually have a TIA, then the without-fail rate would be
appropriately low. In this case, our ability to detect a
change in the without-rail rate would be impaired.
Fourth, although a six-site sample was sufficient to
provide adequate power, future studies might include a
larger number of facilities. Fifth, the PREVENT program
targeted clinical teams at the participating sites; the
clinicians were the subjects of the implementation and
satisfaction evaluations. Future studies should consider
how best to include patients’ perspectives in implemen-
tation evaluations. Finally, although we plan to deploy
the program nationwide if the effectiveness analyses
indicate that PREVENT improves TIA care quality, an
assessment of scalability during national deployment is
beyond the scope of the planned PREVENT research
activities.
The promise of Learning Healthcare Systems involves
the development of QI programs that are data-driven,
meet the needs of stakeholders, and dynamically adapt
to changes in performance and context. As illustrated by
the PREVENT trial, that promise should likewise extend
to program development and evaluation to assess not
only whether a program works but also how and why it
works.
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